Mission Therapeutics
- Website
- missiontherapeutics.com
- Total Funding
- $130.6M
- Last Round
- $13.3M Venture RoundOct 2025
- Rounds
- 5
About
USP30 deubiquitylase inhibitor for mitochondrial diseases
Summary
It has raised $130.6M in total across 5 rounds, most recently a $13.3M Venture Round round in Oct 2025. Investors include Pfizer Venture Investments, Imperial Innovations and Sofinnova Partners.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
$13.3M
Oct 2025
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.